483 related articles for article (PubMed ID: 8806796)
1. Intrathecal administration of antibodies against LFA-1 and against ICAM-1 suppresses experimental allergic encephalomyelitis in rats.
Kawai K; Kobayashi Y; Shiratori M; Sobue G; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1996 Aug; 171(2):262-8. PubMed ID: 8806796
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against leukocyte function-associated antigen-1 and against intercellular adhesion molecule-1 together suppress the progression of experimental allergic encephalomyelitis.
Kobayashi Y; Kawai K; Honda H; Tomida S; Niimi N; Tamatani T; Miyasaka M; Yoshikai Y
Cell Immunol; 1995 Sep; 164(2):295-305. PubMed ID: 7544693
[TBL] [Abstract][Full Text] [Related]
3. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
Jung S; Toyka K; Hartung HP
Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
[TBL] [Abstract][Full Text] [Related]
4. Short term treatment with soluble neuroantigen and anti-CD11a (LFA-1) protects rats against autoimmune encephalomyelitis: treatment abrogates autoimmune disease but not autoimmunity.
Willenborg DO; Staykova MA; Miyasaka M
J Immunol; 1996 Sep; 157(5):1973-80. PubMed ID: 8757317
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of suppression of experimental autoimmune encephalomyelitis by intravenous administration of myelin basic protein: role of regulatory spleen cells.
Hilliard BA; Kamoun M; Ventura E; Rostami A
Exp Mol Pathol; 2000 Feb; 68(1):29-37. PubMed ID: 10640452
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.
Archelos JJ; Jung S; Mäurer M; Schmied M; Lassmann H; Tamatani T; Miyasaka M; Toyka KV; Hartung HP
Ann Neurol; 1993 Aug; 34(2):145-54. PubMed ID: 7687838
[TBL] [Abstract][Full Text] [Related]
7. Experimental allergic encephalomyelitis (EAE): role of B cell and T cell epitopes in the development of EAE in Lewis rats.
Hashim GA; Day ED; Carvalho E; Abdelaal A
J Neurosci Res; 1987; 17(4):375-83. PubMed ID: 2442406
[TBL] [Abstract][Full Text] [Related]
8. Combined nasal administration of encephalitogenic myelin basic protein peptide 68-86 and IL-10 suppressed incipient experimental allergic encephalomyelitis in Lewis rats.
Xu LY; Yang JS; Huang YM; Levi M; Link H; Xiao BG
Clin Immunol; 2000 Sep; 96(3):205-11. PubMed ID: 10964538
[TBL] [Abstract][Full Text] [Related]
9. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
Hinrichs DJ; Roberts CM; Waxman FJ
J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
[TBL] [Abstract][Full Text] [Related]
10. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis.
Gold DP; Schroder K; Powell HC; Kelly CJ
Eur J Immunol; 1997 Nov; 27(11):2863-9. PubMed ID: 9394811
[TBL] [Abstract][Full Text] [Related]
11. Suppression of experimental uveitis with monoclonal antibodies to ICAM-1 and LFA-1.
Uchio E; Kijima M; Tanaka S; Ohno S
Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2626-31. PubMed ID: 7909311
[TBL] [Abstract][Full Text] [Related]
12. The role of serum factors in the suppression of experimental allergic encephalomyelitis: evidence for immunoregulation by antibody to the encephalitogenic peptide.
MacPhee IA; Day MJ; Mason DW
Immunology; 1990 Aug; 70(4):527-34. PubMed ID: 1697565
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of experimental autoimmune encephalomyelitis by staphylococcal enterotoxin D.
Matsumoto Y; Fujiwara M
Cell Immunol; 1993 Jul; 149(2):268-78. PubMed ID: 7687198
[TBL] [Abstract][Full Text] [Related]
14. Experimental allergic encephalomyelitis supernatant transfer activity (EAE-STA) in Lewis rats:immunobiologic and initial biochemical properties.
Whitacre CC; Paterson PY
J Immunol; 1980 Apr; 124(4):1784-8. PubMed ID: 6965962
[TBL] [Abstract][Full Text] [Related]
15. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
Stohl W; Gonatas NK
J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
[TBL] [Abstract][Full Text] [Related]
16. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
Jung S; Donhauser T; Toyka KV; Hartung HP
J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
[TBL] [Abstract][Full Text] [Related]
17. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.
Matsumoto Y; Hara N; Tanaka R; Fujiwara M
J Immunol; 1986 May; 136(10):3668-76. PubMed ID: 3084638
[TBL] [Abstract][Full Text] [Related]
19. Induction of resistance to active experimental allergic encephalomyelitis by myelin basic protein-specific Th2 cell lines generated in the presence of glucocorticoids and IL-4.
Ramírez F; Mason D
Eur J Immunol; 2000 Mar; 30(3):747-58. PubMed ID: 10741389
[TBL] [Abstract][Full Text] [Related]
20. OX-40 antibody enhances for autoantigen specific V beta 8.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis.
Weinberg AD; Lemon M; Jones AJ; Vainiene M; Celnik B; Buenafe AC; Culbertson N; Bakke A; Vandenbark AA; Offner H
J Neurosci Res; 1996 Jan; 43(1):42-9. PubMed ID: 8838572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
